Court Upholds $7M Innogenetics Victory Over Abbott in IP-Infringement Case | GenomeWeb
NEW YORK (GenomeWeb News) — A Wisconsin court has upheld a $7-million verdict against Abbott Laboratories for infringing a patent held by Innogenetics that protects a process for typing HCV isolates, the Belgian biotech said yesterday.
The court also denied Abbott’s motion for a new trial based on “infringement and validity” and granted Innogenetics’ motion to set another hearing to consider permanently barring Abbott from selling the infringing products, Innogenetics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.